CurAccel

CurAccel is a privately-held, global Contract Research Organization (CRO) founded in 2012 and based in Cambridge, Massachusetts. It provides comprehensive clinical trial services from study design through closeout, operating across North America, Europe, Asia/Pacific, and South America. The company differentiates itself through its status as a minority/women-owned business, deep executive engagement, and a pragmatic focus on leveraging experienced personnel rather than rigid processes. Its business model is entirely service-based, generating revenue through fees for clinical trial management, monitoring, and related support services.

Operational and human capital platform focused on experienced personnel, defined project management/monitoring methodologies, and a global site network. Emphasizes a people-centric, pragmatic approach over proprietary software.

Operates in a highly competitive CRO market dominated by large public players (e.g., IQVIA, ICON, Labcorp) and numerous mid-sized and niche competitors. CurAccel differentiates through its ownership status, claimed high level of executive involvement, and flexible, client-centric service model, targeting sponsors who may feel underserved by the largest providers.